2025 is shaping up to be one of the biggest M&A years in history, driven not by volume, but by scale. Despite a volatile first half, global deal value has already surpassed $4.8 trillion, up 41% year-on-year, making this the second-largest M&A year on record, just behind the 2021 boom. Notably, there have been 70...
India’s AM Green and Japan’s Mitsui & Co. have signed a non-binding agreement to explore equity investment and long-term offtake in AM Green’s green aluminium platform — a move that highlights accelerating momentum behind low-carbon industrial metals. 🔋 What stands out Aluminium remains one of the most carbon-intensive industrial materials, largely due to coal-powered smelting....
Reports suggest OpenAI has held early discussions with investors about a potential fundraising round valuing the company at around $750 billion, with the possibility of raising tens of billions — even up to $100 billion. If confirmed, this would mark a ~50% jump from its reported $500 billion valuation just months ago and further reinforce...
The recent crypto market correction has reshaped investor behaviour, hitting the most leveraged and over-hyped segments hardest and accelerating a shift toward more disciplined, risk-managed investment strategies. Bitcoin has fallen roughly 30% from its peak, but losses have been far deeper across bitcoin treasury companies and miners, where valuation premiums, leverage, and funding risk were...
BlackRock and billionaire investor Ray Dalio have pledged support for the Trump administration’s new Invest America (so-called “Trump”) accounts, a federally backed investment initiative for children born between 2025–2028. Under the program, the U.S. Treasury will seed $1,000 per child, invested in a broad stock-market index. Major financial firms, including BlackRock, BNY, Visa, Mastercard, Uber,...
Medline is set to debut on Nasdaq after raising $6.26 billion, marking the largest global IPO of 2025 and one of the biggest private-equity-backed listings on record. Backed by Blackstone, Carlyle, and Hellman & Friedman, the U.S. medical supplies giant priced 216 million shares at $29, above the midpoint of its range — a clear...